It has been shown that molecular biomarkers are sometimes associated with morphological alterations in certain cases, for example, BRAF mutations in melanoma cases have been associated with larger, rounder and more pigmented tumour cells [8], while EGFR-mutant lung adenocarcinomas have been found to be characterised by hobnail cell types [9]. This evidence concerns the gene BRAF and neoplasm.